SOPHiA GENETICS raises €25.0M Series D round
13 September 2017· Rolle, Switzerland· health, ai, biotech, pure_software, b2b
The funding will be directed to growing and improving its artificial intelligence platform for genetic diagnostics, expanding the use of the technology, and increasing the number of centers using the technology.
Investors
LeadBalderton Capital
Also participating
Invoke CapitalAlychlo360º Capital Partners
About SOPHiA GENETICS
Stage
Bridge
Headquarters
Rolle, Switzerland
Founded
2011
Team Size
500+
Sectors
healthaibiotechpure_softwareb2b